Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Construction in Progress (2022 - 2024)

Historic Construction in Progress for Korro Bio (KRRO) over the last 3 years, with Q2 2024 value amounting to $18.3 million.

  • Korro Bio's Construction in Progress changed N/A to $18.3 million in Q2 2024 from the same period last year, while for Jun 2024 it was $18.3 million, marking a year-over-year change of. This contributed to the annual value of $8.2 million for FY2023, which is 31000.0% up from last year.
  • Korro Bio's Construction in Progress amounted to $18.3 million in Q2 2024.
  • Over the past 5 years, Korro Bio's Construction in Progress peaked at $18.3 million during Q2 2024, and registered a low of $2.0 million during Q4 2022.
  • Over the past 3 years, Korro Bio's median Construction in Progress value was $10.8 million (recorded in 2023), while the average stood at $10.5 million.
  • The largest annual percentage gain for Korro Bio's Construction in Progress in the last 5 years was 31000.0% (2023), contrasted with its biggest fall of 31000.0% (2023).
  • Over the past 3 years, Korro Bio's Construction in Progress (Quarter) stood at $2.0 million in 2022, then skyrocketed by 310.0% to $8.2 million in 2023, then skyrocketed by 123.17% to $18.3 million in 2024.
  • Its Construction in Progress was $18.3 million in Q2 2024, compared to $13.4 million in Q1 2024 and $8.2 million in Q4 2023.